Moreover, Wroblova et al. reported a 13.8% mutation rate of the ITPA (94C > A) gene in 188 IBD patients, but no confirmed association was found between its polymorphism and myelosuppression toxicity (Wroblova et al., 2012). This evidence concerns the gene ITPA and inflammatory bowel disease.